ARQT — Arcutis Biotherapeutics, Inc. stock price, charts and financials

QT62Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
26.03
+0.09+0.35%
OverviewShort InterestFilings
ARQTQT62Arcutis Biotherapeutics, Inc.·NASDAQ
26.03+0.35%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 17, 20263Initial statement of beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20264/AStatement of changes in beneficial ownership (amended)
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 11, 2026144Notice of proposed sale of restricted securities
May 11, 2026144Notice of proposed sale of restricted securities
May 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 20264Statement of changes in beneficial ownership
May 06, 20264Statement of changes in beneficial ownership
May 06, 20264Statement of changes in beneficial ownership
#1 / 25 of 506
Page
▼
/ 21